Hirudin variant-1 en es it fr

Hirudin variant-1 Brand names, Hirudin variant-1 Analogs

Hirudin variant-1 Brand Names Mixture

  • No information avaliable

Hirudin variant-1 Chemical_Formula

C288H448N80O110S6

Hirudin variant-1 RX_link

http://www.rxlist.com/cgi/generic3/lepirudin.htm

Hirudin variant-1 fda sheet

Hirudin variant-1 msds (material safety sheet)

Hirudin variant-1 Synthesis Reference

No information avaliable

Hirudin variant-1 Molecular Weight

6983.5

Hirudin variant-1 Melting Point

65 oC (Otto, A. & Seckler, R. Eur. J. Biochem. 202:67-73 (1991))

Hirudin variant-1 H2O Solubility

No information avaliable

Hirudin variant-1 State

Liquid

Hirudin variant-1 LogP

-0.777

Hirudin variant-1 Dosage Forms

Powder for solution; Solution (IV infusion and injection)

Hirudin variant-1 Indication

For the treatment of heparin-induced thrombocytopenia

Hirudin variant-1 Pharmacology

Lepirudin is used to break up clots and to reduce thrombocytopenia. It binds to thrombin and prevents thrombus or clot formation. It is a highly potent, selective, and essentially irreversible inhibitor of thrombin and clot-bond thrombin. Lepirudin requires no cofactor for its anticoagulant action.

Hirudin variant-1 Absorption

No information avaliable

Hirudin variant-1 side effects and Toxicity

No information avaliable

Hirudin variant-1 Patient Information

BIOD00024.html

Hirudin variant-1 Organisms Affected

Humans and other mammals